Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Biofabrication|September 20, 2022
Development of a high-throughput micropatterned agarose scaffold for consistent and reproducible hPSC-derived liver organoidsShanqing Jiang, Fang Xu, Menglong Jin, et al.Hematological Oncology|August 23, 2018
Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in ChinaShuhong Shen, Jiaoyang Cai, Jing Chen, et al.Cancer Research and Treatment|September 29, 2021
Outcomes of Anti-CD19 CAR-T Treatment of Pediatric B-ALL with Bone Marrow and Extramedullary RelapseXinyu Wan, Xiaomin Yang, Fan Yang, et al.Journal of Translational Medicine|March 23, 2023
Safety and efficacy of co-administration of CD19 and CD22 CAR-T cells in children with B-ALL relapse after CD19 CAR-T therapyWenjie Li, Lixia Ding, Wenhua Shi, et al.Cancer Medicine|September 28, 2022
Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemiaWenting Hu, Yin Ting Cheung, Yanjing Tang, et al.Frontiers in Pediatrics|January 28, 2025
Impact of corticosteroids on the efficacy of CD19/22 CAR-T cell therapy in pediatric patients with B-ALL: a single-center studyJing Yang, Jing Zhang, Xinyu Wan, et al.Haematologica|May 22, 2025
Durable remission achieved in pediatric patients with <i>TCF3-HLF</i>-positive relapsed / refractory B-cell acute lymphoblastic leukemia by dual CD19 and CD22-targeted chimeric antigen receptor T-cell therapyXinyu Wan, Tianyi Wang, Jing Yang, et al.Nature Medicine|May 12, 2015
Negative feedback-defective PRPS1 mutants drive thiopurine resistance in relapsed childhood ALLBenshang Li, Hui Li, Yun Bai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2022
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II TrialTianyi Wang, Yanjing Tang, Jiaoyang Cai, et al.Pageof 3